KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Free Cash Flow (2017 - 2025)

Historic Free Cash Flow for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to -$34.8 million.

  • Twist Bioscience's Free Cash Flow fell 4680.96% to -$34.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$86.7 million, marking a year-over-year decrease of 2681.36%. This contributed to the annual value of -$75.6 million for FY2025, which is 934.22% down from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Free Cash Flow is -$34.8 million, which was down 4680.96% from -$24.2 million recorded in Q3 2025.
  • Twist Bioscience's 5-year Free Cash Flow high stood at -$7.3 million for Q2 2024, and its period low was -$74.8 million during Q2 2022.
  • Its 5-year average for Free Cash Flow is -$34.3 million, with a median of -$26.2 million in 2023.
  • Per our database at Business Quant, Twist Bioscience's Free Cash Flow crashed by 12552.35% in 2022 and then surged by 7370.08% in 2024.
  • Twist Bioscience's Free Cash Flow (Quarter) stood at -$59.4 million in 2021, then fell by 10.87% to -$65.9 million in 2022, then skyrocketed by 62.85% to -$24.5 million in 2023, then rose by 3.2% to -$23.7 million in 2024, then crashed by 46.81% to -$34.8 million in 2025.
  • Its Free Cash Flow was -$34.8 million in Q4 2025, compared to -$24.2 million in Q3 2025 and -$10.6 million in Q2 2025.